MCDK was seen in 2.9% of HSK with a rare combina-tion in a study by Je et al.
4. In a review in 1994, only 18 cases were recorded
5. It is always unilateral in live patients as bilateral cases are incompatible with life
6. Renal complications are common with HSK such as pelvicaliectasis, vesicoureteral reflux, duplex kidney, renal stones, MCDK, size discrepancy between kidneys, simple renal cysts, ureteropelvic junction obstruction, ureteral stones, acute pyelonephritis, renal parenchymal disease, ureterovesical junction obstruction, renal trauma and renal tumor
4. The treatment is the surgical resection of the affected kidney
1. In case of small MCDK in an HSK may not be operated because excision involves the risks of damage to the vessels during mobilization of the isthmus and devascularization of the normal segment
7. The presence of MCDK in an HSK may be confirmed via palpable mass close to the midline, rotation or fusion abnormality in the lower poles in USG, polar fusion in DMSA, the degree of involvement of the isthmus and contralateral kidney in CT or MRI
8. Functional imaging of kidneys with radionuclides is used in the diagnosis and the follow up of the kidney diseases. Tc-99m DMSA and Tc-99m DTPA or MAG3 scintigraphies are the most common used nuclear medicine imaging methods. DTPA scintigraphy shows the perfusion, concentration and excretion functions of the kidney. DMSA scintigraphy may show the functioning parenchyma even in the very low functioning kidney in chronic renal disease. In our case, there was not a palpable mass in the abdomen. DMSA and DTPA scintigraphies did not show the HSK exactly because the MCDK is nonfunctional in the inferior pole that cannot show the fusion in the inferior pole. Extension of the right kidney to the left side gave warning of HSK. We think that CT is the best imaging modality for definitive diagnosis of both HSK and MCDK modality as our opinion in this rare combination. But in case of suspicious functioning parenchyma, DMSA scintigraphy is essential to prove it.